United Therapeutics Corporation (UTHR) financial statements (2022 and earlier)

Company profile

Business Address 1040 SPRING ST
SILVER SPRING, MD 20910
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9312,0001,9681,7311,8351,5811,561
Cash and cash equivalents895909942832739670685
Short-term investments1,0361,0921,0258991,096910875
Receivables199213173141157152172
Inventory, net of allowances, customer advances and progress billings94979092878890
Inventory94979092878890
Other current assets100768750884872
Total current assets:2,3242,3862,3182,0142,1671,8681,894
Noncurrent Assets
Property, plant and equipment781727716714732736744
Long-term investments and receivables1,6501,5091,3251,4341,1501,2281,009
Long-term investments1,6501,5091,3251,4341,1501,2281,009
Intangible assets, net (including goodwill), including:45454545158158158
Goodwill28282828282828
Intangible assets, net (excluding goodwill)(6)(6)(6)(6)(6)(5)(5)
Other undisclosed intangible assets, net (including goodwill)22222222136136136
Deferred income tax assets262274264264239256246
Other noncurrent assets108109177171170165167
Total noncurrent assets:2,8462,6632,5272,6272,4482,5432,325
TOTAL ASSETS:5,1695,0494,8454,6414,6154,4114,219
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:175211190165187177153
Accounts payable4   4  
Accrued liabilities171   183  
Other undisclosed accounts payable and accrued liabilities 211190165 177153
Other liabilities28262530405041
Other undisclosed current liabilities1028497107973261
Total current liabilities:305320311302323259255
Noncurrent Liabilities
Long-term debt and lease obligation800800800800800800800
Long-term debt, excluding current maturities800800800800800800800
Liabilities, other than long-term debt105999493976971
Other liabilities105999493976971
Total noncurrent liabilities:905899894893897869871
Total liabilities:1,2101,2191,2051,1961,2201,1281,126
Stockholders' equity
Stockholders' equity attributable to parent3,9593,8303,6403,4453,3953,2833,094
Common stock1111111
Treasury stock, value(2,579)(2,579)(2,579)(2,579)(2,579)(2,579)(2,579)
Additional paid in capital2,2452,2262,1972,1732,1492,1262,105
Accumulated other comprehensive loss(23)(20)(19)(17)(14)(5)(2)
Retained earnings4,3154,2034,0403,8683,8393,7403,569
Total stockholders' equity:3,9593,8303,6403,4453,3953,2833,094
TOTAL LIABILITIES AND EQUITY:5,1695,0494,8454,6414,6154,4114,219

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues415445447379385380362
Cost of revenue(275)(112)(121)(83)(96)(103)(80)
Cost of goods and services sold(35)(28)(37)(23)(35)(24)(26)
Other undisclosed gross profit467      
Gross profit:608333326296289277282
Operating expenses29(104)(103)(361)(224)(56)(142)
Other undisclosed operating loss(467)      
Operating income (loss):170229222(65)65221141
Nonoperating income (expense)(29)(24)(6)9749(2)(7)
Investment income, nonoperating4445567
Other nonoperating income (expense)(29)(24)(3)9749(0)(8)
Interest and debt expense(5)(5)(5)(5)(5)(5)(6)
Income from continuing operations before equity method investments, income taxes:13620021228110214128
Other undisclosed income from continuing operations before income taxes5555556
Income from continuing operations before income taxes:14120421733114219134
Income tax expense(28)(42)(44)(4)(16)(48)(27)
Net income available to common stockholders, diluted:1121631732899171107

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income:1121631732899171107
Other undisclosed comprehensive income6      
Comprehensive income:1181631732899171107
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(9)(2)(2)(3)(10)(2)1
Comprehensive income, net of tax, attributable to parent:1091611712689169109

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: